Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV001267057 | SCV001445238 | pathogenic | Inborn genetic diseases | 2017-02-22 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002504383 | SCV002810371 | likely pathogenic | McKusick-Kaufman syndrome; Bardet-Biedl syndrome 6 | 2022-05-25 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003770393 | SCV004577651 | pathogenic | Bardet-Biedl syndrome; McKusick-Kaufman syndrome | 2023-04-25 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with MKKS-related conditions. For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 985902). This variant is present in population databases (rs756259125, gnomAD 0.007%). This sequence change creates a premature translational stop signal (p.His84Argfs*6) in the MKKS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MKKS are known to be pathogenic (PMID: 11179009, 28761321, 30614526). |